tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Geoff Meacham, 183 are a BUY (59.22%), 97 are a HOLD (31.39%), 29 are a SELL (9.39%).
Analyst Geoff Meacham works at BAML with a stock forecast success ratio of 69.22% fulfilled within 215.8 days on average.
Geoff Meacham’s has documented 596 price targets and ratings displayed on 51 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on BIIB, Biogen at 12-Apr-2024.
Analyst best performing recommendations are on OMER (OMEROS).
The best stock recommendation documented was for PTCT (PTC THERAPEUTICS) at 8/8/2018. The price target of $43 was fulfilled within 1 day with a profit of $2.28 (5.6%) receiving and performance score of 55.99.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
205
$22.5 (12.33%)
2 years 11 months 21 days ago
3/5 (60%)
$35.09 (20.65%)
938
Hold
173
$-9.5 (-5.21%)
156
2 years 11 months 23 days ago
14/24 (58.33%)
$2.73 (1.60%)
682
Hold
190
$7.5 (4.11%)
194
3 years 2 months 22 days ago
9/11 (81.82%)
$34.41 (22.12%)
350
Hold
166
$-16.5 (-9.04%)
175
3 years 2 months 22 days ago
23/23 (100%)
$10.41 (6.69%)
828
Buy
155
3 years 3 months 19 days ago
7/7 (100%)
$36.79 (31.12%)
395
Which stock is Geoff Meacham is most bullish on?
Which stock is Geoff Meacham is most reserved on?
What Year was the first public recommendation made by Geoff Meacham?
